Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 2Spinal Cord Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasms by Histologic Type 1Meningioma 1Medulloblastoma 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Familial ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 15Filgrastim 13Cyclophosphamide 9Carboplatin 9Granulocyte Colony-Stimulating Factor 7Etoposide 7Thiotepa 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Vorinostat 4Busulfan 4sonidegib 3ribociclib 3Vincristine 3Topotecan 3O(6)-benzylguanine 3Magnetic Resonance Spectroscopy 3Irinotecan 3Automobiles 3veliparib 2sargramostim 2pembrolizumab 2fludarabine 2etoposide phosphate 2Valproic Acid 2Thalidomide 2Surgical Procedures, Operative 2Stem Cell Transplantation 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Medulloblastoma × emvododstat × Clear all
NCT01158300 2015-05-04

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
28 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Meningioma, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡